CHRNA3 anticorps (N-Term)
Aperçu rapide pour CHRNA3 anticorps (N-Term) (ABIN633761)
Antigène
Voir toutes CHRNA3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- CHRNA3 antibody was raised against the N terminal of CHRNA3
-
Purification
- Affinity purified
-
Immunogène
- CHRNA3 antibody was raised using the N terminal of CHRNA3 corresponding to a region with amino acids EHRLFERLFEDYNEIIRPVANVSDPVIIHFEVSMSQLVKVDEVNQIMETN
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
CHRNA3 Blocking Peptide, (ABIN937844), is also available for use as a blocking control in assays to test for specificity of this CHRNA3 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CHRNA3 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CHRNA3 (Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3))
-
Autre désignation
- CHRNA3
-
Sujet
- The CHRNA3 subunit is expressed in the soma of the majority of pyramidal cells, with the most alpha 3 immunoreactivity observed in CA2-4 and entorhinal cortex and relatively less in CA1 and subicular pyramidal cell soma.
-
Poids moléculaire
- 57 kDa (MW of target protein)
-
Pathways
- Synaptic Membrane
Antigène
-